Li-Jen Su

Title: Innovations of Li-Jen Su in Liver Fibrotic Injury Detection

Introduction

Li-Jen Su is a notable inventor based in Chiayi, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of liver fibrotic injury. His innovative work has the potential to improve the diagnosis and management of liver diseases.

Latest Patents

Li-Jen Su holds a patent for a method of detecting liver fibrotic injury, which includes fibrosis and/or cirrhosis. The patent describes a process that assays biological samples for differential expression of at least one gene encoding a protein chosen from SEQ ID NO: 1-SEQ ID NO: 63 and their human orthologs. The differential expression of these genes suggests the presence of liver fibrosis or cirrhosis. Additionally, the invention provides a kit containing nucleic acid probes or antibodies for detecting liver fibrosis and/or cirrhosis by analyzing the differential expression of proteins encoded by SEQ ID NO: 1-SEQ ID NO: 63 and their human orthologs. This patent represents a significant advancement in the field of liver disease diagnostics.

Career Highlights

Throughout his career, Li-Jen Su has worked with esteemed organizations such as the Industrial Technology Research Institute and the National Health Research Institutes. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical technology.

Collaborations

Li-Jen Su has collaborated with several professionals in his field, including Hui-Chu Hsieh and Tzu-Ling Tseng. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Li-Jen Su's contributions to the detection of liver fibrotic injury through innovative methods and patents highlight his role as a significant inventor in the medical field. His work not only enhances diagnostic capabilities but also paves the way for better patient outcomes in liver disease management.